Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Novaestiq Unveils Platform of Innovations; Poised to Disrupt the US Aesthetic Market 2024-01-08 22:28
YS Biopharma Announces Changes to its Board Committees 2024-01-08 21:00
Novel Technology Transforms Baldness Treatment Using Beard and Body Hair 2024-01-08 21:00
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries 2024-01-08 20:30
The World's First Clinical Base Editing Therapy for Hemoglobinopathy 2024-01-08 19:46
Clarivate Identifies Thirteen Potential Blockbuster Drugs and Gamechangers in Annual Drugs to Watch Report 2024-01-08 16:00
Guardant Health and Hikma Partner to Offer Cancer Screening and Comprehensive Genomic Profiling Tests in the Middle East and North Africa 2024-01-08 15:30
2024 Trend Forecast for Cosmetic Surgery & Medical Aesthetics in Singapore 2024-01-08 09:00
Juniper Biologics Clinches Prestigious Molecular Science & Technology Acquisition of the Year Award at the Acquisition International M&A Awards 2023 2024-01-08 09:00
Suvoda Announces 30% Growth in 2023 Driven by Strong Customer Adoption of New Suvoda Platform and Products 2024-01-08 08:00
Kexing Biopharm Introduces Eribulin Mesylate Injection, Expanding Its Overseas Product Portfolio 2024-01-05 19:44
Nanoform Commenced Relative Bioavailability Study of Nanotechnology-Enhanced Enzalutamide 2024-01-05 14:35
Therabody, the Global Leader In Wellness Technology, Defends Against Recent Patent Infringement Lawsuit Filed by Hyperice 2024-01-05 06:33
Greenway Health Earns Frost & Sullivan's 2023 North American Revenue Cycle Management Customer Value Leadership Award for Consistently Delivering Products and Services that Enhance Health Providers and Patients Experiences 2024-01-05 04:30
Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications 2024-01-05 00:19
JW Therapeutics Announces NMPA Acceptance of the Supplemental Biological License Application for Carteyva® in Patients with Relapsed or Refractory Mantle Cell Lymphoma 2024-01-04 21:40
Avenzo Therapeutics Announces Global License of AVZO-021 (ARTS-021), a Potentially Best-in-Class Clinical Stage CDK2 Inhibitor from Allorion Therapeutics 2024-01-04 21:02
Telix to Present at the 42nd Annual J.P. Morgan Healthcare Conference 2024-01-04 06:20
Mr. Chong-Yoon Lim, Chairman of COREE Group emphasizes "Creative destruction and Healthcare 4.0" [New Year Message at X-Twitter SNS] 2024-01-03 22:00
Turn Biotechnologies' Expanded eTurna™ Delivery Platform Designed to Solve Delivery and Targeting Issues that Challenge Industry 2024-01-03 22:00
1 60 61 62 63 64 531